RAnolaZine Efficacy in diabetic patients undergoing Percutaneous Coronary Intervention: beyond its anti-ischemic efficacy (RAZE Trial)
Project objectivesA prospective, randomized study aimed at verifying the efficacy of treatment with ranolazine (375 mg bid for one week, 500 mg bid for 15 weeks), in addition to standard anti-ischemic and antiplatelet therapy, on endothelial function, platelet activation and glycometabolic control of diabetic patients undergoing angioplasty with stent. |
Start and end date |
|
Pending approval from the Ethics Committee |
Project Manager |
|
Coordinating institution of the project |
|
Università Campus Bio-Medico di Roma |
